Key Insights

Highlights

Treatment Research

2 treatments under study, led by Mri Andor Ct

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02278744Phase 1Active Not RecruitingPrimary

Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery

Showing all 1 trials

Research Network

Common Treatments

  • Mri Andor Ct1
  • Singlefraction Radiation1

Active Sponsors

  • Memorial Sloan Kettering Cancer Center1

Top Investigators

Activity Timeline